Fischer Medical
Medical Devices · FISCHER
Small CapHealthcareHigh Growth
Ravindran Govindan
Chairman and Managing Director · Pragmatic
Company DNA
Innovation-Led
About
Fischer Medical is a Small Cap company in the Healthcare sector, listed on NSE as FISCHER. With a market cap of ₹2K Cr and revenue of ₹111 Cr, it is currently in the High Growth phase. Known for its Innovation-Led culture and Disruptor approach to innovation, the company operates at a Startup-Speed pace. Operating in the high-growth medical device sector requiring product iteration and clinical compliance focus. Its strategic mandate: Requires R&D-led product differentiation to capture market share in the competitive Indian medical equipment sector.
FAQ
What kind of company is Fischer Medical?
Fischer Medical is a Small Cap Healthcare company (FISCHER) in the High Growth phase with a market cap of ₹2K Cr. It is classified as Innovation-Led in culture.
What is Fischer Medical's culture and work environment like?
Fischer Medical has a Innovation-Led culture with Disruptor innovation DNA and a Startup-Speed pace of execution. Employee brand: Learning Ground. Customer relationship style: B2B-Enterprise. Operating in the high-growth medical device sector requiring product iteration and clinical compliance focus.
Who leads Fischer Medical?
Fischer Medical is led by Ravindran Govindan (Chairman and Managing Director), a Pragmatic leader with 20 years of experience.
What are Fischer Medical's financials?
Fischer Medical reported revenue of ₹111 Cr in FY25 with a 5-year revenue CAGR of —. Operating margin: 1.5%. Market cap: ₹2K Cr.
Culture & Strategy
CultureInnovation-Led
InnovationDisruptor
PaceStartup-Speed
PurposeMission-First
CustomerB2B-Enterprise
EmployeeLearning Ground
BrandTechnical-Expert
LifecycleHigh Growth
Operating in the high-growth medical device sector requiring product iteration and clinical compliance focus.
Mandate
Requires R&D-led product differentiation to capture market share in the competitive Indian medical equipment sector.
Requires R&D-led product differentiation to capture market share in the competitive Indian medical equipment sector.
Financials
Revenue FY25₹111 Cr
PAT FY25₹1 Cr
Rev CAGR 5Y—
OPM1.5%
NPM1.1%
ROE0.4%
ROCE0.4%
P/E57.7
Fwd P/E—
P/B6.1
D/E10.3
Mkt Cap₹2K Cr
Promoter77%
Institutional2.6%
Similar Culture
Could You Lead Fischer Medical?
Take the Genome Benchmark →